Imaging Endpoints is a pioneer and global leader in radiomics.

Radiomics is a rapidly growing field of radiology that extracts high-dimensional data from standard of care CT images to define a novel set of quantifiable imaging patterns – an imaging biomarker. Imaging Endpoints is a pioneer and global leader in this high-demand field of radiology. We are now using radiomics to improve detection of COVID-19, assess the extent of organ damage, primarily in the lungs, and predict patient outcomes. Learn more about our efforts at https://imagingendpoints.com/covid-19/covid-19-radiomic-analysis/.